UK regulators grant licence for three-parent IVF technique

Organisation: Position: Deadline Date: Location:

Britain’s fertility regulator has granted doctors the first UK licence to create babies using a three-parent IVF technique designed to prevent inherited genetic diseases. Reuters Health reports that the license, granted to a team of doctors in Newcastle, northern England, means the first child created in Britain using the mitochondrial pronuclear transfer technique could be born before the end of this year.

Critics of the treatment say it is a dangerous step that will lead to the creation of genetically modified “designer babies”. But the medical team at the Newcastle Fertility Centre said they were delighted with the decision “to help families affected by these devastating diseases”.

“Many years of research have led to the development of pronuclear transfer as a treatment to reduce the risk of mothers transmitting disease to their children,” said Mary Herbert, a professor of reproductive biology at the Centre. “It’s a great testament to the regulatory system here in the UK that research innovation can be applied in treatment.”

The technique involves intervening in the fertilisation process to remove mitochondria, which act as tiny energy-generating batteries inside cells, and which – if faulty – can cause fatal heart problems, liver failure, brain disorders, blindness and muscular dystrophy.

The reports says the treatment is known as “three-parent” IVF because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a female donor. It is designed to help families with mitochondrial diseases – incurable conditions passed down the maternal line that affect around one in 6,500 children worldwide.

The report says Britain’s parliament voted last year to change the law to allow the treatments if and when they were ready for licensing. But the regulator, the Human Fertilisation and Embryology Authority (HFEA), still had to approve each clinic and each patient on an individual basis before the treatment can be carried out.

Fertility specialists have welcomed the decision. Simon Fishel, MD of CARE Fertility, said it was “excellent news” and “a milestone that all who care about medical health will welcome”. Allan Pacey, a fertility expert at Sheffield University, said it was “a great day for science”.

The report says while Britain has been at the forefront of scientific advances and ethical debate about pro-nuclear transfer techniques, it will not be the first country in the world to have children born using 3-parent IVF treatment. The world’s first and so-far only known mitochondrial transfer baby was born in 2016 after US doctors working at a clinic in Mexico helped a Jordanian couple conceive using the treatment.

Reuters Health report

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.